amcp_nw_logo     mer_logo     10th annynoanny ie logo_large
Post-Activity Survey and Evaluation
Reviewing the Evidence Supporting Real-Time Continuous Glucose Monitoring (rtCGM): Opportunities for Patient Engagement and Quality Improvement in Managed Care Pharmacy

Click here to download the slides from this event.

April 13, 2023
In an effort to better determine the overall effectiveness of continuing education activities, we are conducting a brief survey. Listed below are questions for which we would like your responses. All information obtained will be used and reported in aggregate only, without individual attribution. Thank you for your participation.

If you have any questions please contact us at

*All questions are required.
Medical Education Resources (MER) is committed to excellence in continuing education, and your opinions are critical to us in this effort.  To assist us in evaluating the effectiveness of this activity and to make recommendations for future educational offerings, please take a few minutes to complete this evaluation form.

You must complete this evaluation form to receive acknowledgment for completing this activity.
Q1.1 CMS coverage eligibility for continuous glucose monitoring (CGM) includes patients with which of the following characteristics?
Q1.2 HbA1c outcomes associated with the use of CGM are unrelated to household income, insurance status, ethnicity, or age.
Q1.3 Within your practice and/or organizational setting, when applicable, how often do you plan to utilize and/or support the use of CGM to improve patient engagement for lifestyle change and behavior modification?
Q1.4 What is your specialty?
  Q1.4a. Please explain "other".
Q1.5 What best describes your primary role?
  Q1.5a. Please explain "other".
Q1.6 How many years have you been in your area of responsibility?
Q1.7 Approximately how many people with diabetes are being managed in your organization, practice setting, or affiliated organizations?
Q1.8 Rate how well the activity supported your achievement of these learning objectives.
  Assess clinical evidence and expert recommendations supporting the use of CGM in patients with type 1 and type 2 diabetes          
  Characterize the value of rtCGM in improving diabetes outcomes via patient engagement and behavior modification          
  Describe the role of managed care pharmacy professionals in facilitating appropriate CGM access and utilization          
Q1.9 Please select the extent to which you agree/disagree that the speakers achieved the following:
Effective in Presenting the Material
  Nicole Ehrhardt, MD          
  Carly Rodriguez, PharmD, FAMCP          
  Jeff Dunn, PharmD, MBA          
Q1.10 Please select the extent to which you agree/disagree that the speakers achieved the following:
Avoided Commercial Bias or Influence
  Nicole Ehrhardt, MD          
  Carly Rodriguez, PharmD, FAMCP          
  Jeff Dunn, PharmD, MBA          
Q1.11 Rate how well the activity achieved the following.
  The content was evidence based          
  The educational material provided useful information for my practice          
  The activity enhanced my current knowledge base          
  The activity provided appropriate and effective opportunities for active learning (eg, case studies, discussion, Q&A, etc)          
  The opportunities provided to assess my own learning were appropriate (eg, questions before, during or after the activity)          
Q1.12 This activity was designed to promote the core competencies for interprofessional collaborative practice.  Which of these competencies will you apply to enhance your interprofessional healthcare team?  (select all that apply)
Q1.13 Based upon your participation in this activity, do you intend to change your practice and/or administrative behavior?
Q1.15 If you plan to change your practice and/or administrative behavior, what type of changes do you plan to implement?
(check all that apply)
  Q1.15a. Please specify "other".
Q1.16 How confident are you that you will be able to make your intended changes?
Q1.17 Which of the following do you anticipate will be the primary barrier to implementing these changes?
  Q1.17a. Please specify "other".
Q1.18 Was the content of this activity fair, balanced, objective, and free of commercial bias?
  Q1.18a. Please explain.
Q1.28 Type of Credit
FOR PHARMACISTS: Upon submission of your evaluation you will be redirected to a web page with instructions to submit your credit to CPE Monitor.

You must follow the instructions to claim credit.

If you have any questions please email